Article Information
History
- January 15, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- 1Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, 1230 York Avenue, New York, NY 10065 USA
- 2Department of Surgery, Weill Cornell Medicine, New York, NY, 10065, USA
- 3Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, 10065, USA
- 4Department of Cell and Developmental Biology, Weill Cornell Medicine, New York, NY, 10065, USA
- 5Genomics Resource Facility, The Rockefeller University, New York, NY, 10065, USA
- ↵*Lead contact: Rohit Chandwani, MD, PhD; Correspondence: roc9045{at}med.cornell.edu
Posted January 15, 2023.
Control of enhancer activation in the type I interferon response by the histone demethylase Kdm4d / JMJD2d
